Adverse Effects of Class I Antiarrhythmic Drugs
Authors:
- 1 July 1997
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 17 (1) , 8-36
Abstract
Class I antiarrhythmic drugs are characterised by their ability to block the fast inward sodium current in cardiac muscle tissue. However, at the same time, they can be responsible for various...Keywords
This publication has 97 references indexed in Scilit:
- Classifying Antiarrhythmic Actions: By Facts or SpeculationThe Journal of Clinical Pharmacology, 1992
- Propafenone for Cardiac ArrhythmiasThe American Journal of the Medical Sciences, 1992
- The Role of Genetically Determined Polymorphic Drug Metabolism in the Beta-Blockade Produced by PropafenoneNew England Journal of Medicine, 1990
- Delayed awakening due to lidocaine overdoseJournal of Clinical Anesthesia, 1990
- Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction.Circulation, 1979
- MexiletineDrugs, 1979
- Role of concentration-dependent plasma protein binding in disopyramide dispositionJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Effect of Acetylator Phenotype on the Rate at Which Procainamide Induces Antinuclear Antibodies and the Lupus SyndromeNew England Journal of Medicine, 1978
- Ventricular Premature Beats and Mortality after Myocardial InfarctionNew England Journal of Medicine, 1977
- Serum Procainamide Levels As Therapeutic GuidesClinical Pharmacokinetics, 1977